CPC Advisors LLC Takes Position in Cardinal Health, Inc. $CAH

CPC Advisors LLC purchased a new position in shares of Cardinal Health, Inc. (NYSE:CAH) in the 3rd quarter, according to its most recent Form 13F filing with the SEC. The firm purchased 14,572 shares of the company’s stock, valued at approximately $2,287,000.

A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in CAH. GRIMES & Co WEALTH MANAGEMENT LLC bought a new stake in shares of Cardinal Health in the third quarter valued at about $815,000. Quent Capital LLC bought a new stake in Cardinal Health in the 3rd quarter valued at about $35,000. PKO Investment Management Joint Stock Co acquired a new position in shares of Cardinal Health during the 3rd quarter worth approximately $471,000. Nordea Investment Management AB increased its holdings in shares of Cardinal Health by 542.2% during the third quarter. Nordea Investment Management AB now owns 150,705 shares of the company’s stock worth $23,567,000 after purchasing an additional 127,238 shares during the period. Finally, Tokio Marine Asset Management Co. Ltd. raised its position in shares of Cardinal Health by 2.4% in the third quarter. Tokio Marine Asset Management Co. Ltd. now owns 8,853 shares of the company’s stock valued at $1,390,000 after buying an additional 206 shares in the last quarter. 87.17% of the stock is owned by institutional investors and hedge funds.

Cardinal Health Stock Up 0.7%

Cardinal Health stock opened at $202.42 on Tuesday. The stock has a market cap of $48.10 billion, a PE ratio of 30.53, a P/E/G ratio of 1.46 and a beta of 0.65. Cardinal Health, Inc. has a 12-month low of $119.25 and a 12-month high of $214.93. The business’s 50-day moving average price is $204.29 and its two-hundred day moving average price is $173.48.

Cardinal Health (NYSE:CAH) last posted its quarterly earnings results on Thursday, October 30th. The company reported $2.55 earnings per share for the quarter, beating analysts’ consensus estimates of $2.22 by $0.33. The company had revenue of $64.01 billion for the quarter, compared to the consensus estimate of $59.41 billion. Cardinal Health had a net margin of 0.68% and a negative return on equity of 84.37%. The firm’s quarterly revenue was up 22.4% compared to the same quarter last year. During the same period last year, the company posted $1.88 EPS. Cardinal Health has set its FY 2026 guidance at 9.650-9.850 EPS. As a group, analysts expect that Cardinal Health, Inc. will post 7.95 earnings per share for the current year.

Cardinal Health Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Thursday, January 15th. Stockholders of record on Friday, January 2nd will be paid a $0.5107 dividend. This represents a $2.04 dividend on an annualized basis and a dividend yield of 1.0%. The ex-dividend date is Friday, January 2nd. Cardinal Health’s dividend payout ratio is presently 30.77%.

Analysts Set New Price Targets

A number of equities research analysts recently issued reports on CAH shares. Leerink Partners increased their price target on Cardinal Health from $211.00 to $230.00 and gave the stock an “outperform” rating in a research report on Monday, November 17th. Mizuho set a $222.00 target price on Cardinal Health in a report on Monday. Jefferies Financial Group set a $220.00 price target on Cardinal Health and gave the company a “buy” rating in a research note on Monday, November 3rd. Deutsche Bank Aktiengesellschaft upped their price objective on shares of Cardinal Health from $195.00 to $208.00 and gave the stock a “hold” rating in a research report on Tuesday, November 18th. Finally, Citigroup raised shares of Cardinal Health from a “neutral” rating to a “buy” rating and raised their target price for the company from $190.00 to $244.00 in a report on Friday. Fourteen equities research analysts have rated the stock with a Buy rating and two have given a Hold rating to the company. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus target price of $213.40.

Cardinal Health Company Profile

Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.

The company’s core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.